🇺🇸 FDA
Patent

US 8722616

Anti-HIV peptides and methods of use thereof

granted A61KA61K2039/525A61K31/18

Quick answer

US patent 8722616 (Anti-HIV peptides and methods of use thereof) held by BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA
Grant date
Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K2039/525, A61K31/18, A61K38/00, A61K38/04